BioSig Technologies regains Nasdaq compliance

BioSig Technologies announced today that it received notice from the Nasdaq market that it regained compliance.

Westport, Connecticut-based BioSig regained compliance with the minimum bid price requirement. Shares of BSGM closed at or above $1 apeice for a period of 10 consecutive days earlier this month. The compliance period took place between Feb. 6 and Feb. 17.

Shares of BSGM currently sit at $1.29 apiece.

Additionally, Nasdaq notified the company that it complies with its listing rule by meeting an alternative standard. That standard relates to the market value of listed securities (MVLS). BioSig’s MVLS stood at $35 million or greater for a period of 11 consecutive business days (Jan. 31, 2023, to Feb. 17, 2023).

Per the notices, Nasdaq considers both matters closed, BioSig said in a news release

BioSig develops a biomedical signal processing platform for electrocardiogram (ECG) and intra-cardiac signals. Its Pure EP system combines hardware and software to enable the real-time acquisition of raw signal data. The technology achieves this absent of unnecessary noise or interference.

According to BioSig, Pure EP allows physicians to make informed clinical decisions based on clear and precise data. Pure EP heightens visualization of active signals to facilitate personalized patient care. MassDevice